
Changes to Biohit Oyj’s management
02.05.2012 09:30
INTERIM REPORT OF THE BIOHIT GROUP 1 JANUARY TO 31 MARCH 2012
26.04.2012 09:30
The diagnostic product range of Biohit includes the GastroPanel examinations, which are used to aid diagnosis of Helicobacter pylori infection and atrophic gastritis from a blood sample. They are also ideal tools for identification of patients at increased risk of gastric cancer, peptic ulcer disease, gastroesophageal reflux disease (GERD) and deficiencies of vitamin B12, calcium and iron. In addition to this, Biohit offers several enzyme-linked immunosorbent assay tests (ELISA), and Quick tests for the detection of
An acid-free stomach is the primary risk factor in gastric cancer. According to recent research, it is also a significant risk factor in oesophageal cancer. Acetium® is a CE marked product developed and patented by Biohit Oyj. It is intended for persons with a low-acid or anacidic stomach
Biohit also develops and manufactures monoclonal antibodies for use in cancer diagnosis and as components for immunoassay kits.
Adopting a systems approach, Biohit also provides some laboratory instruments, such as microplate readers and washers, as well as liquid handling products to support Biohit ELISA tests.
Biohit Service laboratory promotes the evaluation and adoption of Biohit’s diagnostic tests and analysing systems.
| Diagnostics product catalogue |